NEW YORK, NY. May 1 — The Lupus Research Alliance (LRA) launches its Breaking through for Lupus Research: 20 Years of Progress campaign today in observance of Lupus Awareness Month. The organization will be celebrating the scientific discoveries that have brought the greatest hope to the lupus community. The LRA has invested over $200 million […] READ MORE
NEW YORK, NY. April 29. Lupus can harm many organs in the body, including the kidneys. A new study led by Dr. Hans Haecker of St. Jude Children’s Research Hospital in Memphis found that the cells that provoke kidney damage are different than those that injure other organs. In part funded by a grant from […] READ MORE
NEW YORK, NY. March 28 – Lupus Research Alliance earned a 4-star rating from Charity Navigator, America’s largest independent charity evaluator. Awarded for its strong financial health and commitment to accountability and transparency, the Lupus Research Alliance has earned this distinction every year since its founding in 2016. Using objective analysis, Charity Navigator has […] READ MORE
WASHINGTON, DC – March 19. Lupus Research Alliance (LRA), the world’s largest private funder of lupus research, celebrates its 15th Annual Advocate for Lupus Research Day on Capitol Hill today, sounding the need for increased federal funding to further advance new lupus treatments and a cure. Advocates representing the Lupus Research Alliance are on the […] READ MORE
NEW YORK, NY. March 6, 2019. Depleting the number of harmful B cells with a novel immunotherapy that employs modified T cells may offer an effective strategy to treat lupus, according to a new study funded by the Lupus Research Alliance. These findings offer a renewed optimism for the elimination of B cells to provide […] READ MORE
New York, NY– March 1. The Lupus Research Alliance and its affiliate, Lupus Therapeutics announced a collaboration with Takeda Pharmaceutical Company Limited, to evaluate the investigational biologic TAK-079 as a potential new therapy for lupus in a Phase 1 trial (NCT03724916). The national study will be conducted in 20 research centers throughout the country, many […] READ MORE
February 28, 2019 NEW YORK, NY. As a co-sponsor of the National Institutes of Health (NIH) public-private Accelerating Medicines Partnership (AMP), the Lupus Research Alliance is proud to share the project’s five-year achievements reported in Nature Reviews Drug Discovery. In the article, NIH Director Dr. Francis Collins points to new technology standards AMP created for […] READ MORE
NEW YORK, NY. February 19. Pieces of bacteria that escape from the intestines may trigger lupus and associated disease flares in some patients, according to a new study partly funded by the Lupus Research Alliance. These findings may allow disease treatment with probiotics or diets that alter the mix of bacterial species in the intestines. […] READ MORE
February 1, 2019 Today, Lupus Therapeutics, an affiliate of Lupus Research Alliance, is launching our Patient Advocates for Lupus Studies (PALS) program with a pilot study to determine its effectiveness in increasing awareness of and participation in lupus clinical trials, particularly among diverse populations. The program will pair people with lupus interested in learning about […] READ MORE
February 1, 2019 The Lupus Research Alliance announced that its affiliate Lupus Therapeutics is working with the pharmaceutical company, Janssen, to help conduct a Phase 3 trial to evaluate whether their drug ustekinumab (Stelara®) may offer benefit to people with lupus. Called LOTUS, the international study is being conducted in over 200 sites, 20 of […] READ MORE
NEW YORK, NY – January 10. Can “borrowed” drugs for treating other diseases protect the skin in patients with lupus? Can researchers coax the body to weed out harmful immune cells that drive tissue destruction in lupus? Those are just two of the innovative approaches for lupus therapies recognized by the Lupus Research Alliance with […] READ MORE
NEW YORK, NY. December 20. The Board of Directors and staff of the Lupus Research Alliance mourn the death of Stephen Katz, MD, PhD, a true champion for the lupus community. For over two decades, Dr. Katz has served as Director of the home institute for lupus at the National Institutes of Health (NIH), the […] READ MORE
